MSD in Clonmel chosen as engineering partner by MIT

Massachusetts Institute of Technology (MIT) has chosen leading Irish pharmaceutical company, MSD, as its first Irish partner for the innovative engineering programme The Practice School.

Massachusetts Institute of Technology (MIT) has chosen leading Irish pharmaceutical company, MSD, as its first Irish partner for the innovative engineering programme The Practice School.

Eight international graduate students from Asia, US and India, arrived to MSD’s facility in Ballydine, Clonmel, to take part in the programme as part of their studies with MIT. The Ballydine facility was selected given its cutting-edge role in healthcare technology and innovation and for the key role it plays in the commercialisation of new treatments for patients.

The students, based at MSD’s facility, under the supervision of their MIT station director worked on live intensive projects of real strategic value to MSD all the while learning and leveraging the skills of the Irish MSD team. In return, the graduate students gain exposure to a wide variety of real-world problems, technical ability and professionalism.

Ger Carmody, site lead at MSD’s facility in Ballydine, said: “MSD have a bespoke graduate and intern programme with various technology and chemistry schools in Ireland. We are extremely proud that our site was chosen, out of our global network, to take part in this unique programme with such an esteemed institution as MIT.

“Not only will the students gain invaluable experience but we as a company benefit from having a unique perspective on our day-to-day operations. We have a complex and exciting pipeline here in Ballydine – across MSD’s Global network our site is recognised as a world class site for innovative medicines.”